GH1 and hepatocellular carcinoma: Liver steatosis, fibrosis and HCC development are also induced following disruption of GH-STAT5 signaling in mouse liver [35–37], where the metabolic effects of GH signaling loss linked to fatty liver development are more pronounced in males than females [38].